Although poorly used as an augmentation strategy in resistant depression, the association of lithium is a good therapeutic option to consider in case of partial or insufficient response to the initial antidepressant. Various studies show significant efficacy of this treatment in combination with antidepressants: the practical aspects of implementation and monitoring are also discussed in this paper.